Collaborations with sponsors are very valuable to us. Therefore, we are continuously striving to provide the best possible services. To facilitate this, we work together with Customeyes - an independent research organization specialized in B2B customer and stakeholder surveys - to conduct yearly qualitative and quantitative customer satisfaction interviews. We use the results of these surveys to improve where and if possible.
Working with CHDR
Our customers speak about their experience. Please note that the views expressed here are the sole opinion of CHDR’s sponsors.
“Perfectly suited to providing innovative research”
Every aspect of a study at CHDR is well-thought-out and clearly executed. This approach is evident even from minor operational aspects such as their IT infrastructure and the design of their building and office space to optimise patient management and patient flow.
Our work with CHDR is generally geared towards developing new methodologies; so by definition it’s highly innovative. CHDR is uniquely suited to tackle difficult scientific problems and challenges. Importantly, CHDR’s researchers are driven by an innate curiosity.
Experimental Medicine Director,
Large Biotech Firm
“Other CROs deliver only standard endpoints, whereas CHDR gives clear added value.”
Because CHDR is a non-profit organisation, they stand out from other CROs. CHDR channels their revenue back into training, and they are closely involved with the medical school. I’m not aware of any other CRO that does this. Other CROs deliver only standard endpoints, whereas CHDR gives clear added value.
I see CHDR as lying somewhere between a supplier and a business partner. Thus, CHDR is clearly a supplier in the sense that we pay them to conduct our clinical studies, but they also add considerable value as a conventional CRO, based on their in-depth academic background, expertise, and knowledge. In particular, their academic expertise is extremely valuable.
Senior Clinical Director,
Top 10 Big Pharma Company
“CHDR provides more than just medical expertise.”
Their ability to combine outstanding science with highly effective study execution makes CHDR unique. They go far beyond simply providing medical and research expertise; they bring in people who are highly motivated, invested in the project, and top-notch researchers. This approach is quite different from most other CROs. Because CHDR is a non-profit foundation, they can focus on delivering high-quality research, including cutting-edge technology and implementation.
VP of Clinical Operations,
“Very good at responding to feedback.”
CHDR is a very science-focused organisation with high operational efficiency. CHDR is particularly good at listening to feedback from sponsors and then acting upon it. In addition to being highly responsive, they also provide valuable feedback. I recommend CHDR to any research organisation that’s looking for a CRO that goes above and beyond standard research.
Top 10 Big Pharma Company
“A research partner, not just a vendor.”
When we first started working with CHDR, we viewed them as a vendor. But as we saw how they work, their valuable input, and their ability to take control of the situation, we realised that they would be better suited as a partner.
CHDR is a unique CRO: because they are a non-profit organisation, their revenue is channeled back into research and training. We appreciate this commitment to helping move science forward. CHDR employs researchers with the training and dedication needed to successfully perform early-phase, high-quality experiments using methodologies that must first be established and validated. Very few CROs have the level of professionalism and motivation that CHDR possesses. CHDR’s mindset is clear: Tell us what you’re after, and we’ll help you find the right solution
Vice-President of Experimental Medicine,
“Top-notch scientific support and subject recruitment.”
In a clinical trial, the most important elements are medical and scientific support and ensuring the safety of the participants. In all of these aspects, CHDR meets our full expectations.
Head of Clinical Pharmacology,
Top 50 Pharma Company